Merck & Co., Inc. (New York Stock Exchange:MRK)

About the company

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The Alliances segment includes results from the company's relationship with AstraZeneca LP related to sales of Nexium and Prilosec. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

71000

CEO

Kenneth C. Frazier

Exchange

New York Stock Exchange

Website

http://www.merck.com

$48B

Total Revenue

71K

Employees

$202B

Market Capitalization

19.93

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$34B

Operating Margin (in %)

Total operating margin

$13B

Net Margin (in %)

Total net margin

$10B

Dividend Yield (in %)

Dividend per share

$2.32

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 382409.47 82729.00 6.14 22.29 20.75
Merck & Co., Inc. MRK 201995.52 48081.00 7.58 19.93 21.10
Pfizer Inc. PFE 191963.22 50660.00 2.91 12.15 31.17
Eli Lilly & Co. LLY 155261.34 23087.00 52.69 27.37 23.97
AbbVie, Inc. ABBV 147435.40 34057.00 -23.60 17.58 24.65
Bristol Myers Squibb Co. BMY 111646.60 31006.00 2.71 94.92 3.08
Repligen Corp. RGEN 6331.14 286.00 6.07 275.87 8.11
Reata Pharmaceuticals, Inc. RETA 4824.84 20.00 22.85 -15.52 -150.30
Nektar Therapeutics NKTR 4248.64 137.00 3.32 -9.25 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 4053.40 1.00 37.48 -6.20 None
Allakos, Inc. ALLK 3236.42 None 7.03 -34.60 None
Karuna Therapeutics, Inc. KRTX 2853.24 None 7.45 -70.35 None
ADC Therapeutics SA ADCT 2565.54 2.00 30.26 -22.00 None
OPKO Health, Inc. OPK 2332.47 891.00 1.66 -7.98 -32.92
Turning Point Therapeutics, Inc. TPTX 2259.72 None 6.80 -18.91 None
IGM Biosciences, Inc. IGMS 2237.27 None 9.86 -41.24 None
Apellis Pharmaceuticals, Inc. APLS 2175.36 None 9.61 -5.22 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Springworks Therapeutics, Inc. SWTX 1639.59 None 5.33 -26.30 None
Zymeworks, Inc. ZYME 1622.04 26.00 3.37 -9.56 -629.37
Principia Biopharma, Inc. PRNB 1590.96 30.00 5.67 -22.64 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1578.42 None 9.67 -17.13 None
Akcea Therapeutics, Inc. AKCA 1341.51 341.00 2.75 -47.69 -8.59
Tricida, Inc. TCDA 1310.26 None 6.74 -6.20 None
Kiniksa Pharmaceuticals Ltd. KNSA 1305.15 None 6.76 -10.79 None
Arcutis Biotherapeutics, Inc. ARQT 1184.00 None 5.05 -18.93 None
Odonate Therapeutics, Inc. ODT 1121.14 None 9.18 -9.96 None
Akero Therapeutics, Inc. AKRO 1074.74 None 8.97 -21.18 None
Athenex, Inc. ATNX 1064.70 123.00 6.53 -9.89 -87.86
Phibro Animal Health Corp. PAHC 1060.26 818.00 5.35 28.73 4.49
Constellation Pharmaceuticals, Inc. CNST 966.40 None 4.55 -10.41 None
G1 Therapeutics, Inc. GTHX 818.52 1.00 3.54 -6.24 None
Phathom Pharmaceuticals, Inc. PHAT 794.00 None 4.40 -2.92 None
Gossamer Bio, Inc. GOSS 793.61 None 3.22 -3.99 None
Quanterix Corp. QTRX 732.51 60.00 6.46 -16.75 -71.52
Krystal Biotech, Inc. KRYS 731.00 None 4.26 -35.25 None
Aprea Therapeutics, Inc. APRE 714.00 None 6.32 -21.12 None
Applied Therapeutics, Inc. APLT 711.70 14.00 4.60 -14.44 -19.41
Oric Pharmaceuticals, Inc. ORIC 691.05 None -7.50 -22.85 None
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Arcturus Therapeutics Holdings, Inc. ARCT 645.58 19.00 59.83 -23.21 -151.34
Amneal Pharmaceuticals, Inc. AMRX 621.98 1679.00 4.28 -2.86 -11.85
Keros Therapeutics, Inc. KROS 606.78 8.00 -27.41 -28.57 -285.35
Oyster Point Pharma, Inc. OYST 548.10 None 5.51 -9.53 None
Mirum Pharmaceuticals, Inc. MIRM 486.50 None 3.16 -7.18 None
Fulcrum Therapeutics, Inc. FULC 476.10 1.00 8.02 -6.90 None
Satsuma Pharmaceuticals, Inc. STSA 476.00 None 4.68 -13.08 None
SIGA Technologies, Inc. SIGA 475.60 19.00 5.32 -24.17 -94.00
89bio, Inc. ETNB 462.70 None 5.71 -7.17 None
Biospecifics Technologies Corp. BSTC 462.28 40.00 3.75 19.77 61.80
Imara, Inc. IMRA 438.60 None 4.24 -12.46 None
Crinetics Pharmaceuticals, Inc. CRNX 414.72 1.00 5.24 -7.11 -447.78
DURECT Corp. DRRX 405.48 28.00 31.14 -16.77 -82.94
Kala Pharmaceuticals, Inc. KALA 391.56 6.00 4.28 -4.27 None
Relmada Therapeutics, Inc. RLMD 373.32 0.00 5.57 -31.19 -877.66
TCR2 Therapeutics, Inc. TCRR 373.20 None 2.55 -37.02 None
Ocular Therapeutix, Inc. OCUL 367.20 6.00 -45.00 -4.01 None
Ovid Therapeutics, Inc. OVID 344.25 None 8.14 -5.28 None
Osmotica Pharmaceuticals Plc OSMT 343.44 232.00 2.61 -1.25 -115.44
Urovant Sciences Ltd. UROV 302.10 None -5.36 -2.09 None
Aeglea Biotherapeutics, Inc. AGLE 300.30 4.00 9.48 -3.74 -523.27
HOOKIPA Pharma, Inc. HOOK 282.88 13.00 2.56 -6.25 -333.02
IDEAYA Biosciences, Inc. IDYA 270.40 None 4.11 -6.20 None
Spero Therapeutics, Inc. SPRO 268.28 12.00 3.53 -3.30 -656.72
AMAG Pharmaceuticals, Inc. AMAG 268.26 321.00 1.02 -0.72 -115.05
Verrica Pharmaceuticals, Inc. VRCA 257.50 None 4.70 -8.44 None
Lannett Co., Inc. LCI 252.32 542.00 0.86 -8.30 -5.77
Gritstone Oncology, Inc. GRTS 227.88 4.00 2.04 -2.18 None
Kaleido Biosciences, Inc. KLDO 221.10 None 7.84 -3.02 None
KalVista Pharmaceuticals, Inc. KALV 211.68 12.00 2.34 -6.53 -263.38
Veru, Inc. VERU 207.35 39.00 6.93 -21.27 -25.53
Protara Therapeutics, Inc. TARA 191.34 None 2.88 -12.41 None
Galera Therapeutics, Inc. GRTX 187.25 None 3.50 -2.85 None
Sutro Biopharma, Inc. STRO 184.92 41.00 3.51 -3.03 -148.06
LogicBio Therapeutics, Inc. LOGC 179.63 1.00 5.42 -4.22 None
Liquidia Technologies, Inc. LQDA 173.14 8.00 13.57 -3.51 -602.17
Cyclerion Therapeutics, Inc. CYCN 156.60 6.00 1.97 -1.51 None
Avenue Therapeutics, Inc. ATXI 155.20 532.00 28.53 -10.66 26.69
Tyme Technologies, Inc. TYME 144.90 None 8.40 -6.63 None
Evelo Biosciences, Inc. EVLO 143.36 None 5.27 -1.64 None
scPharmaceuticals, Inc. SCPH 138.32 119.00 3.53 -4.41 -27.05
PhaseBio Pharmaceuticals, Inc. PHAS 134.85 2.00 2.50 -2.82 None
Harrow Health, Inc. HROW 133.38 51.00 8.55 -5.40 -47.54
Lyra Therapeutics, Inc. LYRA 129.96 1.00 -1.10 -7.79 -491.16
Aquestive Therapeutics, Inc. AQST 128.24 49.00 -7.39 -1.82 -139.64
Mustang Bio, Inc. MBIO 128.00 None 2.99 -2.60 None
NeuBase Therapeutics, Inc. NBSE 123.62 None 51.94 -2.77 None
TFF Pharmaceuticals, Inc. TFFP 118.18 None 4.57 -3.05 None
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
Ayala Pharmaceuticals, Inc. AYLA 115.41 3.00 -2.72 -5.59 -679.19
Evolus, Inc. EOLS 105.30 45.00 1.89 -1.04 -217.51
Eton Pharmaceuticals, Inc. ETON 99.90 1.00 10.88 -5.00 None
Trevi Therapeutics, Inc. TRVI 98.82 None 2.10 -3.37 None
Milestone Pharmaceuticals, Inc. MIST 95.00 None 0.94 -1.53 None
Corvus Pharmaceuticals, Inc. CRVS 79.46 None 1.27 -1.68 None
EyePoint Pharmaceuticals, Inc. EYPT 78.49 26.00 5.54 -1.60 -196.30
Clearside Biomedical, Inc. CLSD 77.49 6.00 9.95 -4.40 -293.61
Checkpoint Therapeutics, Inc. CKPT 76.80 2.00 6.62 -3.31 -949.53
Xeris Pharmaceuticals, Inc. XERS 74.48 4.00 3.69 -0.57 None
Navidea Biopharmaceuticals, Inc. NAVB 67.15 1.00 -49.38 -6.08 -65.13
Baudax Bio, Inc. BXRX 65.70 None -1.79 -0.94 None
BiomX, Inc. PHGE 64.35 None 1.70 -1.50 None
Genprex, Inc. GNPX 59.85 None 5.08 -4.38 None
Assertio Therapeutics, Inc. ASRT 57.60 192.00 1.00 -0.35 -83.99
Aridis Pharmaceuticals, Inc. ARDS 55.44 1.00 -22.81 -1.90 -851.00
Aerpio Pharmaceuticals, Inc. ARPO 52.89 20.00 1.59 -2.80 -51.58
Menlo Therapeutics, Inc. MNLO 49.30 2.00 4.15 -0.53 -483.51
Annovis Bio, Inc. ANVS 47.46 None 4.35 -37.67 None
Eyenovia, Inc. EYEN 45.44 None 4.58 -2.22 None
Edesa Biotech, Inc. EDSA 44.82 0.00 6.38 -0.47 -395.23
Moleculin Biotech, Inc. MBRX 40.02 None 3.48 -4.35 None
Citius Pharmaceuticals, Inc. CTXR 36.45 None 2.70 -2.11 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Mannatech, Inc. MTEX 33.70 156.00 1.42 7.59 3.45
Allena Pharmaceuticals, Inc. ALNA 33.58 None 4.42 -0.77 None
AgeX Therapeutics, Inc. AGE 33.44 2.00 -44.00 -2.75 -658.11
Oncternal Therapeutics, Inc. ONCT 32.50 3.00 4.17 -1.29 -225.89
Aileron Therapeutics, Inc. ALRN 32.20 None 4.42 -1.21 None
Acer Therapeutics, Inc. ACER 31.30 3.00 2.28 -1.20 -274.69
CNS Pharmaceuticals, Inc. CNSP 31.20 None 5.42 -5.74 None
Adamis Pharmaceuticals Corp. ADMP 30.16 22.00 1.16 -1.02 -140.33
Hoth Therapeutics, Inc. HOTH 25.40 None 7.06 -2.82 None
Millendo Therapeutics, Inc. MLND 25.27 0.00 0.60 -0.54 None
Spring Bank Pharmaceuticals, Inc. SBPH 24.64 0.00 0.93 -0.94 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 18.81 1.00 8.25 -1.13 None
ProPhase Labs, Inc. PRPH 17.04 9.00 1.54 -5.68 -31.15
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.33 5.00 -3.29 -0.45 -602.34
Adial Pharmaceuticals, Inc. ADIL 13.80 None 3.37 -1.82 None
PDS Biotechnology Corp. PDSB 12.88 None 1.43 -0.50 None
Titan Pharmaceuticals, Inc. TTNP 12.07 4.00 5.03 -0.67 -437.91
Novus Therapeutics, Inc. NVUS 7.35 None 0.63 -0.35 None
Brickell Biotech, Inc. BBI 4.68 5.00 1.53 -0.06 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Equal Justice Under Law Is Not a Reality, Says Merck CEO

1h ago, source: Bloomberg

Merck & Co. Chief Executive Officer Kenneth Frazier, a lawyer by trade, talks about the fight for equal justice under the law ...

Exclusive: EU secures potential COVID-19 drugs from Roche, Germany's Merck

15h ago, source: Reuters on MSN.com

The deals follow requests from EU states in May to acquire the two drugs and come as governments around the world jostle for ...

AstraZeneca-Merck's Lynparza wins EU approval for pancreatic cancer

8h ago, source: Yahoo! News

(Reuters) - AstraZeneca Plc and Merck & Co Inc said on Wednesday their blockbuster cancer treatment Lynparza won approval in ...

Merck says it has agreed to supply potential COVID-19 drug Rebif to EU countries

53m ago, source: YAHOO!

German drugmaker Merck said on Wednesday it had agreed to supply its potential COVID-19 drug Rebif to European Union countries should orders be placed for the treatment. The comment followed a Reuters ...

Merck Ready to Produce Hundreds of Millions of Doses of Covid-19 Vaccine

1h ago, source: Bloomberg

Merck & Co. Chief Executive Officer Kenneth Frazier says the company is working to develop two vaccines for Covid-19. If one is approved, he says the company is ready to produce hundreds of millions ...

FDA declines to approve Merck and Eisai's liver cancer combo therapy

9h ago, source: Reuters

The U.S. Food and Drug Administration on Wednesday declined to approve a combination of Merck & Co Inc's blockbuster cancer drug Keytruda and Eisai Co Ltd's Lenvima for use in previously untreated ...

Exclusive: EU reaches deals with Roche, Merck for supply of COVID-19 drugs - source

15h ago, source: YAHOO!

The European Commission has reached agreements with pharmaceutical companies Roche and Merck KGaA to supply experimental ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.